⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer

Official Title: A Randomized, Double Blind, Placebo-Controlled Study of the Efficacy and Safety oF MORAb-003(Farletuzumab) in Combination With Paclitaxel Therapy in Subjects With Platinum-Resistant or Refractory Relapsed Ovarian Cancer

Study ID: NCT00738699

Conditions

Ovarian Cancer

Study Description

Brief Summary: The study is being conducted to find out if paclitaxel works better when given together with an experimental drug called MORAb-003 (farletuzumab) or alone in patients with platinum-resistant or refractory relapsed ovarian cancer

Detailed Description: Safety was assessed by the monitoring and recording of all adverse events (AEs), including drug hypersensitivity adverse events (DHAE), and serious adverse events (SAEs); clinical laboratory test (serum chemistry, hematology, urinalysis); tolerability (discontinuations, treatment delays, dose reductions); physical examinations (including vital signs assessment); 12-lead electrocardiograms (ECG) obtained in triplicate and reviewed by independent blinded cardiologist, and Karnofsky's performance status.

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Southern Cancer Center, Mobile, Alabama, United States

St. Joseph's Hospital and Medical Center, Phoenix, Arizona, United States

California Cancer Care, Inc., Greenbrae, California, United States

Moores UC San Diego Cancer Center, La Jolla, California, United States

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Monterey Bay Oncology, Monterey, California, United States

Jupiter Medical Center, Jupiter, Florida, United States

Innovative Medical Research of South Florida, Inc., Miami, Florida, United States

Florida Hospital Cancer Institute, Orlando, Florida, United States

Sarasota Memorial Hospital, Sarasota, Florida, United States

Memorial Health University Medical Center, Savannah, Georgia, United States

Central DuPage Hospital, Winfield, Illinois, United States

St. Vincent Gynecologic Oncology, Indianapolis, Indiana, United States

Hematology and Oncology Specialists, LLC, Metairie, Louisiana, United States

Johns Hopkins Hospital, Baltimore, Maryland, United States

Weinberg Cancer Institute at Franklin Square, Baltimore, Maryland, United States

Henry Ford Health System, Detroit, Michigan, United States

Morristown Memorial Hospital, Morristown, New Jersey, United States

Schwartz Gynecologic Oncology, PLLC, Brightwaters, New York, United States

Arena Oncology Associates, PC, Lake Success, New York, United States

St. Luke's Roosevelt Hospital Center, New York, New York, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Piedmont Hematology Oncology Associates, PA, Winston Salem, North Carolina, United States

Cleveland Clinic, Cleveland, Ohio, United States

Signal Point Clinical Research Center, Middletown, Ohio, United States

Cancer Care Associates, Tulsa, Oklahoma, United States

Abington Memorial Hospital, Abington, Pennsylvania, United States

Magee-Women's Hospital of UPMC, Pittsburgh, Pennsylvania, United States

Medical University of South Carolina, Charleston, South Carolina, United States

International Beneficence Clinical Research, LLC, Harlingen, Texas, United States

South Texas Oncology & Hematology PA, San Antonio, Texas, United States

Scott & White Memorial Hospital and Clinic, Temple, Texas, United States

Utah Cancer Specialists, Salt Lake City, Utah, United States

Northern Virginia Pelvic Surgery Associates, Annandale, Virginia, United States

Prince of Wales Hospital, Randwick, New South Wales, Australia

Westmead Hospital, Westmead, New South Wales, Australia

Royal Brisbane & Women's Hospital, Herston, Queensland, Australia

The Burnside War Memorial Hospital, Inc., Toorak Gardens, South Australia, Australia

Monash Medical Centre, East Bentleigh, Victoria, Australia

Mercy Hospital for Women, Heidelburg, Victoria, Australia

The Royal Women's Hospital, Parkville, Victoria, Australia

Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia

St. John of God Hospital, Subiaco, Western Australia, Australia

AZ Greninge Hospital, Kortrijk, , Belgium

University Hospitals Leuven, Leuven, , Belgium

CHU de Liege, Liege, , Belgium

Tom Baker Cancer Centre, Calgary, Alberta, Canada

BC Cancer Agency, Kelowna, British Columbia, Canada

Juravinski Cancer Centre, Hamilton, Ontario, Canada

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

UMCG, Groningen, , Netherlands

University Hospital Maastricht, Maastricht, , Netherlands

UMC Utrecht, Utrecht, , Netherlands

Hospital Universitario Son Dureta, Palma de Mallorca, Baleares, Spain

Hospital de Son Llatzer, Palma de Mallorca, Baleares, Spain

Hospital de Mataro, Mataro, Barcelona, Spain

Corporacio Sanitaria Parc Taulis, Sabadell, Barcelona, Spain

Consorci Sanitari de Terrassa, Terrassa, Barcelona, Spain

Fundacion Hospital Alcorcon, Alcorcon, Madrid, Spain

Hospital Clinic I Provincial, Barcelona, , Spain

Hospital Universitario 12 de Octubre, Madrid, , Spain

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: